On September 7, when the whole country welcomed the 20th National Congress of the Communist Party of China, China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. (hereinafter referred to as China Resources Medical Devices) and Keya Medical Technology Co., Ltd. Sign a comprehensive strategic cooperation agreement to seek high-quality development of county hospitals in my country. The signing of the contract comes at the right time, with strong strategic complementarity, a deep degree of cooperation and a high degree of cooperation consensus. The goal is to work together to promote the further sinking of high-quality medical resources to the grassroots level, continue to improve the comprehensive capacity of county hospitals, meet the needs of people in the county for basic medical services, and achieve “serious illnesses not in the county”. Chen Wei, Assistant General Manager of China Resources Pharmaceutical Commercial Group, Wang Xingkai, Chairman of China Resources Medical Devices, Li Bing, Director of Marketing Center, Wang Liwei, Chairman and CEO of Keya Medical, and Jiao Tong, Vice President, attended and signed a strategic cooperation memorandum on behalf of the two companies.
It is reported that the two parties will give full play to their respective advantages, relying on artificial intelligence technology in Internet + county medical care in all-round coordination and multi-level cooperation, with the development of medical quality as the core, use high-tech means to promote the improvement of county-level diagnosis and treatment capabilities, and help medical institutions to build a close-knit medical institution. The county medical community seeks well-being for the health of the people.
Strategic cooperation signing ceremony site
The signing ceremony of strategic cooperation (the first on the left is Wang Liwei, Chairman and CEO of Keya Medical, and the first on the right is Wang Xingkai, Chairman of China Resources Medical Devices)
Chen Wei, Assistant General Manager of China Resources Pharmaceutical Commercial Group, mentioned at the signing ceremony that the original intention of this cooperation between the two parties is to proceed from the national policy requirements. According to the “Thousand-County Project” County Hospital Comprehensive Capacity Improvement Work Plan (2021-2025) issued by the National Health Commission in 2021, it clarifies the overall requirements for the “Thousand-County Project” county hospital comprehensive capacity improvement work. The goal is that by 2025, at least 1,000 county hospitals across the country will reach the level of tertiary hospital medical services. Based on this background, with the mission of “creating a better life together”, China Resources Medical Devices and Keya Medical are both support for national policies and full trust in Keya’s product technology. It is hoped that we will jointly innovate the service model, create excellent medical products and high-quality services suitable for the county according to local conditions, help areas with limited resources to strengthen the construction of specialist capabilities, and gradually improve the diagnosis and treatment of common and frequently-occurring diseases in the county. some contribution.
Wang Liwei, Chairman and CEO of Keya Medical, said in his speech: In the “Healthy China Action (2019-2030)”, the “Cardiovascular and Cerebrovascular Disease Prevention Action” is included in one of the 15 major special actions. Keya Medical’s artificial intelligence products have been intensively cultivated long ago. The self-developed Shenmai score and Shenmai Ling analysis products cover three major clinical application fields: wisdom heart, wisdom brain, and wisdom chest. Clinical use has been carried out in more than 1,100 hospitals in 28 provinces, municipalities and autonomous regions across the country. “We must strengthen the sense of mission and responsibility, take the initiative to take responsibility, focus on big data and artificial intelligence technology and fully consider the actual application in county medical institutions.” Keya Medical Chairman and CEO Wang Liwei proposed his vision. With original AI technology as the core driving force, Keya Medical has conducted in-depth research on the needs of clinical scenarios, and has applied artificial intelligence in the diagnosis, treatment and management of cardiovascular diseases, from disease screening and diagnosis to treatment. Helping doctors to determine treatment strategies in the process, or its application in chronic disease management, will promote the diagnosis and treatment of diseases such as cardiovascular medicine in the county and the discipline construction of related departments. Wang Liwei believes that the core purpose of medical AI products is to help reduce costs and increase efficiency, and improve the level of medical institutions at all levels. A win-win situation for the government, hospitals and patients.
The picture shows the cardiologist of the Chinese People’s Liberation Army General Hospital using the deep pulse fraction DVFFR to diagnose and treat patients
It is believed that with the implementation of the comprehensive strategic cooperation between China Resources Medical Devices and Keya Medical, the two parties will continue to enhance consensus, complement each other’s resource advantages, give full play to their professional and brand advantages, better serve the health of the Chinese people, and promote the vigorous and orderly development of my country’s medical and health industry. , to help the “Healthy China 2030 Goal” to be realized as soon as possible!
This article is reprinted from: https://www.leiphone.com/category/industrynews/4Cyy62uWLdGsJDcf.html
This site is for inclusion only, and the copyright belongs to the original author.